vs
Side-by-side financial comparison of BRT Apartments Corp. (BRT) and STEM, INC. (STEM). Click either name above to swap in a different company.
STEM, INC. is the larger business by last-quarter revenue ($47.1M vs $24.3M, roughly 1.9× BRT Apartments Corp.). BRT Apartments Corp. runs the higher net margin — -17.8% vs -33.9%, a 16.1% gap on every dollar of revenue. On growth, BRT Apartments Corp. posted the faster year-over-year revenue change (1.3% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs 1.9%).
BRT Apartments Corp is a publicly traded real estate investment trust that owns, operates, and develops multi-family residential properties primarily across high-growth markets in the United States. Its core portfolio consists of garden-style and mid-rise apartment communities, serving diverse renter groups while targeting long-term asset value appreciation and stable dividend returns for its shareholders.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
BRT vs STEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $24.3M | $47.1M |
| Net Profit | $-4.3M | $-16.0M |
| Gross Margin | — | 48.9% |
| Operating Margin | -14.3% | -17.7% |
| Net Margin | -17.8% | -33.9% |
| Revenue YoY | 1.3% | -15.6% |
| Net Profit YoY | -108.7% | 68.8% |
| EPS (diluted) | $-0.23 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $24.3M | $47.1M | ||
| Q3 25 | $24.4M | $38.2M | ||
| Q2 25 | $24.2M | $38.4M | ||
| Q1 25 | $24.1M | $32.5M | ||
| Q4 24 | $24.0M | $55.8M | ||
| Q3 24 | $24.4M | $29.3M | ||
| Q2 24 | $23.9M | $34.0M | ||
| Q1 24 | $23.4M | $25.5M |
| Q4 25 | $-4.3M | $-16.0M | ||
| Q3 25 | $-2.7M | $-23.8M | ||
| Q2 25 | $-2.6M | $202.5M | ||
| Q1 25 | $-2.4M | $-25.0M | ||
| Q4 24 | $-2.1M | $-51.1M | ||
| Q3 24 | $-2.2M | $-148.3M | ||
| Q2 24 | $-2.3M | $-582.3M | ||
| Q1 24 | $-3.2M | $-72.3M |
| Q4 25 | — | 48.9% | ||
| Q3 25 | — | 35.5% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | — | 27.6% | ||
| Q1 24 | — | -95.0% |
| Q4 25 | -14.3% | -17.7% | ||
| Q3 25 | -13.7% | -33.6% | ||
| Q2 25 | -12.2% | -34.8% | ||
| Q1 25 | -11.3% | -65.0% | ||
| Q4 24 | -14.3% | -84.4% | ||
| Q3 24 | -11.7% | -493.2% | ||
| Q2 24 | -11.6% | -1705.5% | ||
| Q1 24 | -14.0% | -267.0% |
| Q4 25 | -17.8% | -33.9% | ||
| Q3 25 | -11.1% | -62.2% | ||
| Q2 25 | -10.6% | 527.8% | ||
| Q1 25 | -9.8% | -76.9% | ||
| Q4 24 | -8.6% | -91.6% | ||
| Q3 24 | -9.0% | -506.3% | ||
| Q2 24 | -9.8% | -1712.6% | ||
| Q1 24 | -13.5% | -283.9% |
| Q4 25 | $-0.23 | $-4.40 | ||
| Q3 25 | $-0.14 | $-2.84 | ||
| Q2 25 | $-0.14 | $-1.79 | ||
| Q1 25 | $-0.12 | $-0.15 | ||
| Q4 24 | $-0.10 | $-15.29 | ||
| Q3 24 | $-0.12 | $-18.24 | ||
| Q2 24 | $-0.13 | $-71.81 | ||
| Q1 24 | $-0.17 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $25.1M | $48.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $177.2M | $-249.4M |
| Total Assets | $709.8M | $308.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $25.1M | $48.9M | ||
| Q3 25 | $21.1M | $43.1M | ||
| Q2 25 | $23.6M | $40.8M | ||
| Q1 25 | $24.4M | $58.6M | ||
| Q4 24 | $27.9M | $56.3M | ||
| Q3 24 | $45.8M | $75.4M | ||
| Q2 24 | $18.9M | $89.6M | ||
| Q1 24 | $21.3M | $112.8M |
| Q4 25 | $177.2M | $-249.4M | ||
| Q3 25 | $186.7M | $-235.7M | ||
| Q2 25 | $192.1M | $-214.1M | ||
| Q1 25 | $198.5M | $-417.5M | ||
| Q4 24 | $205.0M | $-398.4M | ||
| Q3 24 | $209.9M | $-344.1M | ||
| Q2 24 | $214.7M | $-203.2M | ||
| Q1 24 | $220.7M | $371.6M |
| Q4 25 | $709.8M | $308.9M | ||
| Q3 25 | $714.2M | $362.6M | ||
| Q2 25 | $699.6M | $379.2M | ||
| Q1 25 | $703.9M | $405.1M | ||
| Q4 24 | $713.5M | $437.4M | ||
| Q3 24 | $717.7M | $537.8M | ||
| Q2 24 | $694.7M | $691.5M | ||
| Q1 24 | $699.5M | $1.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.1M | $8.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.1M | $8.2M | ||
| Q3 25 | $9.1M | $11.4M | ||
| Q2 25 | $8.5M | $-21.3M | ||
| Q1 25 | $246.0K | $8.5M | ||
| Q4 24 | $24.1M | $-14.7M | ||
| Q3 24 | $9.0M | $-9.4M | ||
| Q2 24 | $6.9M | $-11.9M | ||
| Q1 24 | $653.0K | $-621.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BRT
| Unconsolidated Joint Ventures | $13.2M | 54% |
| Other | $11.1M | 46% |
STEM
Segment breakdown not available.
